A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of Daily OCID 4681-S-01 Administered Orally to Subjects with Advanced Solid Tumors.

Trial Profile

A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of Daily OCID 4681-S-01 Administered Orally to Subjects with Advanced Solid Tumors.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs OCID 4681-S-01 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Sponsors Orchid Chemicals & Pharmaceuticals
  • Most Recent Events

    • 21 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top